MEA1 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
natural killer cell	18 studies	23% ± 9%	Explore
macrophage	12 studies	22% ± 7%	Explore
pericyte	12 studies	22% ± 8%	Explore
CD8-positive, alpha-beta T cell	12 studies	28% ± 9%	Explore
regulatory T cell	12 studies	23% ± 5%	Explore
fibroblast	11 studies	27% ± 10%	Explore
B cell	10 studies	21% ± 4%	Explore
ciliated cell	10 studies	34% ± 12%	Explore
CD4-positive, alpha-beta T cell	10 studies	26% ± 9%	Explore
gamma-delta T cell	10 studies	23% ± 11%	Explore
basal cell	9 studies	31% ± 15%	Explore
non-classical monocyte	9 studies	26% ± 8%	Explore
CD16-negative, CD56-bright natural killer cell, human	9 studies	22% ± 5%	Explore
classical monocyte	9 studies	20% ± 4%	Explore
smooth muscle cell	9 studies	25% ± 7%	Explore
T cell	8 studies	23% ± 4%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	8 studies	19% ± 3%	Explore
connective tissue cell	8 studies	26% ± 8%	Explore
mucosal invariant T cell	8 studies	19% ± 3%	Explore
endothelial cell	8 studies	28% ± 11%	Explore
CD16-positive, CD56-dim natural killer cell, human	7 studies	25% ± 5%	Explore
epithelial cell	7 studies	37% ± 17%	Explore
memory B cell	7 studies	20% ± 2%	Explore
naive B cell	7 studies	19% ± 3%	Explore
CD4-positive, alpha-beta memory T cell	6 studies	20% ± 4%	Explore
CD8-positive, alpha-beta memory T cell	6 studies	22% ± 5%	Explore
conventional dendritic cell	6 studies	29% ± 10%	Explore
myofibroblast cell	6 studies	27% ± 6%	Explore
abnormal cell	6 studies	26% ± 8%	Explore
plasmacytoid dendritic cell	6 studies	21% ± 5%	Explore
secretory cell	5 studies	25% ± 15%	Explore
myeloid cell	5 studies	19% ± 6%	Explore
effector CD8-positive, alpha-beta T cell	5 studies	26% ± 5%	Explore
hematopoietic precursor cell	4 studies	26% ± 8%	Explore
plasma cell	4 studies	31% ± 9%	Explore
plasmablast	4 studies	42% ± 20%	Explore
club cell	4 studies	22% ± 6%	Explore
deuterosomal cell	4 studies	33% ± 12%	Explore
effector memory CD8-positive, alpha-beta T cell	4 studies	22% ± 4%	Explore
T follicular helper cell	4 studies	23% ± 4%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	4 studies	20% ± 4%	Explore
effector memory CD4-positive, alpha-beta T cell	4 studies	18% ± 1%	Explore
hematopoietic stem cell	4 studies	21% ± 1%	Explore
mature NK T cell	4 studies	22% ± 1%	Explore
respiratory goblet cell	3 studies	32% ± 15%	Explore
squamous epithelial cell	3 studies	33% ± 18%	Explore
kidney loop of Henle epithelial cell	3 studies	18% ± 2%	Explore
endothelial cell of lymphatic vessel	3 studies	24% ± 8%	Explore
mesothelial cell	3 studies	34% ± 12%	Explore
precursor B cell	3 studies	21% ± 2%	Explore
type I pneumocyte	3 studies	26% ± 9%	Explore
erythroblast	3 studies	30% ± 14%	Explore
effector CD4-positive, alpha-beta T cell	3 studies	22% ± 5%	Explore
endothelial cell of vascular tree	3 studies	20% ± 3%	Explore
exhausted T cell	3 studies	25% ± 2%	Explore
neuron	3 studies	29% ± 16%	Explore
dendritic cell	3 studies	35% ± 12%	Explore
enteroendocrine cell	3 studies	25% ± 13%	Explore
goblet cell	3 studies	22% ± 8%	Explore
double negative thymocyte	3 studies	31% ± 15%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	9 studies	21% ± 2%	Explore
lung	8 studies	28% ± 11%	Explore
kidney	3 studies	21% ± 4%	Explore
lymph node	3 studies	21% ± 5%	Explore
intestine	3 studies	25% ± 12%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
esophagus	100%	1921.89	1445 / 1445	100%	40.64	183 / 183
ovary	100%	1995.34	180 / 180	100%	72.36	430 / 430
uterus	100%	2138.56	170 / 170	100%	72.34	459 / 459
skin	100%	2376.07	1808 / 1809	100%	72.58	472 / 472
brain	100%	2316.49	2639 / 2642	100%	66.10	705 / 705
thymus	100%	1959.40	653 / 653	100%	63.49	604 / 605
pancreas	100%	1017.94	327 / 328	100%	43.61	178 / 178
prostate	100%	2149.29	245 / 245	100%	59.08	500 / 502
intestine	100%	1869.46	966 / 966	99%	47.21	524 / 527
lung	100%	1612.54	577 / 578	99%	55.71	1149 / 1155
stomach	100%	1461.96	359 / 359	99%	44.17	284 / 286
kidney	100%	2070.83	89 / 89	99%	43.13	894 / 901
breast	100%	2049.81	459 / 459	99%	60.57	1109 / 1118
liver	99%	1030.09	224 / 226	100%	48.49	406 / 406
bladder	100%	2388.14	21 / 21	99%	63.76	498 / 504
adrenal gland	100%	2144.15	258 / 258	99%	49.46	227 / 230
adipose	100%	1960.58	1204 / 1204	0%	0	0 / 0
blood vessel	100%	2482.97	1335 / 1335	0%	0	0 / 0
eye	0%	0	0 / 0	100%	74.45	80 / 80
lymph node	0%	0	0 / 0	100%	69.98	29 / 29
spleen	100%	1698.45	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	58.45	45 / 45
ureter	0%	0	0 / 0	100%	50.46	1 / 1
peripheral blood	97%	1404.78	897 / 929	0%	0	0 / 0
heart	97%	1064.27	831 / 861	0%	0	0 / 0
muscle	91%	690.85	734 / 803	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0008584	Biological process	male gonad development
GO_0007283	Biological process	spermatogenesis
GO_0030154	Biological process	cell differentiation
GO_0005737	Cellular component	cytoplasm
GO_0005515	Molecular function	protein binding

IV. Literature review

[source]

Gene name	MEA1
Protein name	Male-enhanced antigen 1 Male-enhanced antigen 1 (MEA-1)
Synonyms	MEA
Description	FUNCTION: May play an important role in spermatogenesis and/or testis development. FUNCTION: May play an important role in spermatogenesis and/or testis development. . FUNCTION: May play an important role in spermatogenesis and/or testis development. .
Accessions	ENST00000643776.1 ENST00000645375.1 A0A2R8Y7W8 ENST00000645410.1 Q16626 A0A2R8Y6W5 ENST00000642748.1 ENST00000244711.4 ENST00000642555.1

MEA1 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review